241 related articles for article (PubMed ID: 23917206)
1. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases.
Song X; Qian Y
Cell Signal; 2013 Dec; 25(12):2335-47. PubMed ID: 23917206
[TBL] [Abstract][Full Text] [Related]
2. The role of inflammasome-derived IL-1 in driving IL-17 responses.
Mills KH; Dungan LS; Jones SA; Harris J
J Leukoc Biol; 2013 Apr; 93(4):489-97. PubMed ID: 23271701
[TBL] [Abstract][Full Text] [Related]
3. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
Iwakura Y; Nakae S; Saijo S; Ishigame H
Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
[TBL] [Abstract][Full Text] [Related]
4. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
Kikly K; Liu L; Na S; Sedgwick JD
Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
[TBL] [Abstract][Full Text] [Related]
5. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
[TBL] [Abstract][Full Text] [Related]
6. IL-17-producing T cells in lung immunity and inflammation.
Nembrini C; Marsland BJ; Kopf M
J Allergy Clin Immunol; 2009 May; 123(5):986-94; quiz 995-6. PubMed ID: 19410688
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 as a drug target in human disease.
Ivanov S; Lindén A
Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
Kramer JM; Gaffen SL
J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
[TBL] [Abstract][Full Text] [Related]
9. Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis.
Deng C; Peng N; Tang Y; Yu N; Wang C; Cai X; Zhang L; Hu D; Ciccia F; Lu L
Front Immunol; 2021; 12():691559. PubMed ID: 34122457
[TBL] [Abstract][Full Text] [Related]
10. The IL-17 Family of Cytokines in Health and Disease.
McGeachy MJ; Cua DJ; Gaffen SL
Immunity; 2019 Apr; 50(4):892-906. PubMed ID: 30995505
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
Goriely S; Cavoy R; Goldman M
Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
[TBL] [Abstract][Full Text] [Related]
12. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.
Monin L; Gaffen SL
Cold Spring Harb Perspect Biol; 2018 Apr; 10(4):. PubMed ID: 28620097
[TBL] [Abstract][Full Text] [Related]
14. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
15. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
16. The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
Martin-Orozco N; Dong C
Curr Opin Investig Drugs; 2009 Jun; 10(6):543-9. PubMed ID: 19513943
[TBL] [Abstract][Full Text] [Related]
17. IL-17 signaling in host defense and inflammatory diseases.
Qian Y; Kang Z; Liu C; Li X
Cell Mol Immunol; 2010 Sep; 7(5):328-33. PubMed ID: 20514051
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 signalling in a murine model of mild chronic asthma.
Herbert C; Shadie AM; Kumar RK
Int Arch Allergy Immunol; 2013; 162(3):253-62. PubMed ID: 24022125
[TBL] [Abstract][Full Text] [Related]
20. Diseases that may benefit from manipulating the Th17 pathway.
Miossec P
Eur J Immunol; 2009 Mar; 39(3):667-9. PubMed ID: 19283719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
